Importantly, treatment regimens were being highly tolerated, with no serious adverse functions claimed. Ketamine-induced dissociative and psychotomimetic symptoms were transient, resolving completely within 1–2 h on average. Nonetheless, results pertaining to efficacy remain combined, with the most important RCT87 failing to detect sizeable dose-similar effects of ketamine on PTSD. Th... https://brianl777hxl4.bimmwiki.com/user